Clinical Trial: DP303c in Patients With HER2-positive Advanced Breast Cancer
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: HER2-positive Advanced Breast Cancer
Study Type: INTERVENTIONAL
Official Title: A Multicentre, Randomized, Open-label, Controlled Phase ? Clinical Study to Evaluate the Efficacy and Safety of DP303cversus Trastuzumab Combined With Vinorelbine/Capecitabine in of HER2-positive
Brief Summary:
This is a study of DP303c in patients with HER2-positive advanced breast cancer.
Read more